Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model

BACKGROUND: Using killed microorganisms or their parts to stimulate immunity for cancer treatment dates back to the end of 19(th) century. Since then, it undergone considerable development. Our novel approach binds ligands to the tumor cell surface, which stimulates tumor phagocytosis. The therapeut...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Cancer
Auteurs principaux: Caisová, Veronika, Vieru, Andra, Kumžáková, Zuzana, Glaserová, Simona, Husníková, Hana, Vácová, Nikol, Krejčová, Gabriela, Paďouková, Lucie, Jochmanová, Ivana, Wolf, Katherine I., Chmelař, Jindřich, Kopecký, Jan, Ženka, Jan
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5142338/
https://ncbi.nlm.nih.gov/pubmed/27927165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2982-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires